Institutional members access full text with Ovid®

Share this article on:

Can SLC19A1 80G>A Polymorphisms Predict Risk of Extremely Delayed MTX excretion After High Dose of Methotrexate?

Rasmussen, Maria Moeller BSc*; Christensen, Regitse Hoejgaard BSc*; Gregers, Jannie MSc, PhD; Heldrup, Jesper MD; Nersting, Jacob MSc, PhD*; Schmiegelow, Kjeld MD, DMSc*,§

Journal of Pediatric Hematology/Oncology: July 2013 - Volume 35 - Issue 5 - p 417–418
doi: 10.1097/MPH.0b013e318290c11c
Letter to the Editor

Departments of *Pediatrics and Adolescent Medicine

Clinical Immunology, University Hospital Rigshospitalet

§Institute of Gynaecology, Obstetrics and Paediatrics, The Faculty of Medicine University of Copenhagen Copenhagen, Denmark

Department of Pediatrics University Hospital Lund Lund, Sweden

Supported by The Danish Childhood Cancer Foundation and The Danish Cancer Society (Grant no. R52-A2819).

The authors declare no conflict of interest.

© 2013 by Lippincott Williams & Wilkins.